ID

24889

Description

Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00571285

Lien

https://clinicaltrials.gov/show/NCT00571285

Mots-clés

Versions (1)
  1. 22/08/2017 22/08/2017 -
Téléchargé le

22 août 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Parkinson's Disease NCT00571285

Anglais

Eligibility Parkinson's Disease NCT00571285

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
eligible participants must be able to provide informed consent or have a legal representative (defined by georgia law) who can give consent.
Description

Informed Consent | Informed Consent Patient Representative

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0030701
diagnosis of ipd, based on history of 2/3 cardinal features of pd (tremor, bradykinesia and rigidity) and definite response to dopaminergic therapy.
Description

Parkinson Disease | Tremor | Bradykinesia | Rigidity | Dopamine Agonists Good therapeutic response

Type de données

boolean

Alias
UMLS CUI [1]
C0030567
UMLS CUI [2]
C0040822
UMLS CUI [3]
C0233565
UMLS CUI [4]
C0026837
UMLS CUI [5,1]
C0178601
UMLS CUI [5,2]
C0184785
previous serum 25-oh vitamin d concentration measured by treating physician within previous 3 months.
Description

25-Oh D Vitamin Test

Type de données

boolean

Alias
UMLS CUI [1]
C1255280
eligible participants must be able to complete the study questionnaires and assessments (e.g., participant must be judged able to complete tug at screening/baseline).
Description

Clinical Trial Subject Questionnaire Completion | TUG Completion

Type de données

boolean

Alias
UMLS CUI [1,1]
C3890411
UMLS CUI [1,2]
C0205197
UMLS CUI [2,1]
C1319201
UMLS CUI [2,2]
C0205197
participants must be free of active cancer or other serious medical condition which might reasonably preclude their completing the 6-month intervention.
Description

Malignant Neoplasm Free of | Medical condition Serious Free of

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332296
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C0332296
participants must be able to complete an 8 meter walk at screening evaluation.
Description

Able to walk Meter Quantity

Type de données

boolean

Alias
UMLS CUI [1,1]
C2712089
UMLS CUI [1,2]
C0475209
UMLS CUI [1,3]
C1265611
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with pd, h&y stage i-iv will be eligible to participate in this study.
Description

Parkinson Disease Hoehn and Yahr grades

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030567
UMLS CUI [1,2]
C0451215
participants must be ages 18-89 years.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
patient with a history of hypercalcemia, hypercalciuria, liver failure, end-stage renal disease (national kidney foundation classification stage 5) or kidney stones within the past 5 years will be excluded.
Description

Hypercalcemia | Hypercalciuria | Liver Failure | Chronic Kidney Failure Chronic kidney disease NKF classification | Kidney Calculi

Type de données

boolean

Alias
UMLS CUI [1]
C0020437
UMLS CUI [2]
C0020438
UMLS CUI [3]
C0085605
UMLS CUI [4,1]
C0022661
UMLS CUI [4,2]
C2074730
UMLS CUI [5]
C0022650
specifically, potential participants with gfr (estimated or measured) <15 ml/min are excluded.
Description

Estimated Glomerular Filtration Rate | Glomerular Filtration Rate

Type de données

boolean

Alias
UMLS CUI [1]
C3811844
UMLS CUI [2]
C0017654
Retour au début de la page

Similar models

Eligibility Parkinson's Disease NCT00571285

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent | Informed Consent Patient Representative
Item
eligible participants must be able to provide informed consent or have a legal representative (defined by georgia law) who can give consent.
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
Parkinson Disease | Tremor | Bradykinesia | Rigidity | Dopamine Agonists Good therapeutic response
Item
diagnosis of ipd, based on history of 2/3 cardinal features of pd (tremor, bradykinesia and rigidity) and definite response to dopaminergic therapy.
boolean
C0030567 (UMLS CUI [1])
C0040822 (UMLS CUI [2])
C0233565 (UMLS CUI [3])
C0026837 (UMLS CUI [4])
C0178601 (UMLS CUI [5,1])
C0184785 (UMLS CUI [5,2])
25-Oh D Vitamin Test
Item
previous serum 25-oh vitamin d concentration measured by treating physician within previous 3 months.
boolean
C1255280 (UMLS CUI [1])
Clinical Trial Subject Questionnaire Completion | TUG Completion
Item
eligible participants must be able to complete the study questionnaires and assessments (e.g., participant must be judged able to complete tug at screening/baseline).
boolean
C3890411 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C1319201 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
Malignant Neoplasm Free of | Medical condition Serious Free of
Item
participants must be free of active cancer or other serious medical condition which might reasonably preclude their completing the 6-month intervention.
boolean
C0006826 (UMLS CUI [1,1])
C0332296 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
Able to walk Meter Quantity
Item
participants must be able to complete an 8 meter walk at screening evaluation.
boolean
C2712089 (UMLS CUI [1,1])
C0475209 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Parkinson Disease Hoehn and Yahr grades
Item
patients with pd, h&y stage i-iv will be eligible to participate in this study.
boolean
C0030567 (UMLS CUI [1,1])
C0451215 (UMLS CUI [1,2])
Age
Item
participants must be ages 18-89 years.
boolean
C0001779 (UMLS CUI [1])
Hypercalcemia | Hypercalciuria | Liver Failure | Chronic Kidney Failure Chronic kidney disease NKF classification | Kidney Calculi
Item
patient with a history of hypercalcemia, hypercalciuria, liver failure, end-stage renal disease (national kidney foundation classification stage 5) or kidney stones within the past 5 years will be excluded.
boolean
C0020437 (UMLS CUI [1])
C0020438 (UMLS CUI [2])
C0085605 (UMLS CUI [3])
C0022661 (UMLS CUI [4,1])
C2074730 (UMLS CUI [4,2])
C0022650 (UMLS CUI [5])
Estimated Glomerular Filtration Rate | Glomerular Filtration Rate
Item
specifically, potential participants with gfr (estimated or measured) <15 ml/min are excluded.
boolean
C3811844 (UMLS CUI [1])
C0017654 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial